Medicare Enrolled
Dr. Guy Bernstein, MD
Optician · Bryn Mawr, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bernstein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bernstein?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bernstein
Dr. Guy Bernstein is an optician specialist in Bryn Mawr, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Bernstein performed 8,890 Medicare services across 3,815 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bernstein received a total of $23,816 from 75 pharmaceutical and/or device companies across 608 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bernstein is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 3% volume in PA
$23,816 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,890
Medicare services
Top 3% in PA for optician
3,815
Unique beneficiaries
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~444 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 1,850 | $2 | $6 |
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
1,500 | $5 | $8 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
1,104 | $3 | $8 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
712 | $70 | $205 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
686 | $38 | $102 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
616 | $95 | $294 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
605 | $50 | $85 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
401 | $8 | $12 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
181 | $66 | $117 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
150 | $65 | $600 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
147 | $2 | $10 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
114 | $120 | $358 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
112 | $8 | $67 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 105 | $127 | $800 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
80 | $126 | $472 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
65 | $47 | $75 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
48 | $146 | $316 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
47 | $75 | $213 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
45 | $29 | $100 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
45 | $663 | $1,147 |
| Hormone pellet insertion under the skin A small hormone pellet is placed just beneath the skin to release medication slowly over time. |
36 | $79 | $178 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
35 | $11 | $62 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
22 | $9 | $169 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
22 | $27 | $250 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
21 | $109 | $455 |
| Bladder tumor removal via endoscope This procedure involves using an endoscope to destroy or remove a large growth from the bladder. |
15 | $310 | $928 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
14 | $141 | $550 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
14 | $116 | $1,000 |
| Ureteral stent insertion via cystoscopy A tube is placed into the ureter using an endoscope inserted through the bladder. |
13 | $69 | $460 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
13 | $109 | $215 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
12 | $316 | $809 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
12 | $27 | $437 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
12 | $167 | $366 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
12 | $118 | $507 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
12 | $295 | $785 |
| Laser vaporization of prostate A procedure that uses a laser to remove excess prostate tissue through an endoscope. The process includes controlling any bleeding that occurs during the treatment. |
12 | $521 | $1,235 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.7% high complexity
27.2% medium
72.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$23,816
Total received (2018-2024)
Avg $3,402/year across 7 years
Top 9% in PA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
75
Companies
608
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,359 (60.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,779 (36.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$678 (2.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,334
2023
$8,564
2022
$2,182
2021
$2,704
2020
$1,652
2019
$1,943
2018
$3,436
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$597
Axonics, Inc.
$433
Bayer Healthcare Pharmaceuticals Inc.
$306
Sumitomo Pharma America, Inc.
$255
Dendreon Pharmaceuticals LLC
$246
ABBVIE INC.
$214
Teleflex LLC
$180
Janssen Scientific Affairs, LLC
$144
Janssen Biotech, Inc.
$129
PFIZER INC.
$101
Medtronic, Inc.
$81
Cook Medical LLC
$72
Tolmar, Inc.
$71
Novartis Pharmaceuticals Corporation
$65
UROGEN PHARMA, INC.
$61
AstraZeneca Pharmaceuticals LP
$60
Merck Sharp & Dohme LLC
$46
IMMUNITYBIO, INC.
$45
Myriad Genetic Laboratories, Inc.
$40
Telix Pharmaceuticals
$39
PROGENICS PHARMACEUTICALS, INC.
$26
Antares Pharma, Inc.
$22
Provepharm Inc.
$21
Ferring Pharmaceuticals Inc.
$19
PROCEPT BioRobotics Corporation
$18
Endo USA, Inc.
$15
Verity Pharmaceuticals Inc.
$15
DENTSPLY IH AB
$13
Top 3 companies account for 40.1% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$7,119
Astellas Pharma US Inc
$2,255
Lutonix, Inc.
$1,000
NeoTract Inc.
$921
Axonics, Inc.
$917
Dendreon Pharmaceuticals LLC
$890
UROVANT SCIENCES INC
$670
PFIZER INC.
$602
Bayer Healthcare Pharmaceuticals Inc.
$517
Cepheid
$492
Teleflex LLC
$485
Bayer HealthCare Pharmaceuticals Inc.
$471
Sumitomo Pharma America, Inc.
$457
Medtronic, Inc.
$447
Avadel Specialty Pharmaceuticals, LLC
$376
Janssen Scientific Affairs, LLC
$372
Endo Pharmaceuticals Inc.
$371
C. R. Bard, Inc. & Subsidiaries
$342
Ferring Pharmaceuticals Inc.
$311
Myriad Genetic Laboratories, Inc.
$276
ABBVIE INC.
$273
Allergan, Inc.
$232
Acerus Pharmaceuticals Corporation
$209
Allergan Inc.
$186
Medtronic USA, Inc.
$161
Merck Sharp & Dohme LLC
$161
Coloplast Corp
$155
AKRIMAX PHARMACEUTICALS, LLC
$152
AbbVie Inc.
$150
Merck Sharp & Dohme Corporation
$143
AbbVie, Inc.
$142
Antares Pharma, Inc.
$137
Boston Scientific Corporation
$133
TOLMAR Pharmaceuticals, Inc.
$115
180 Medical, Inc.
$111
Clarus Therapeutics Inc.
$111
Tolmar, Inc.
$109
Amgen Inc.
$105
Verity Pharmaceuticals Inc.
$102
Progenics Pharmaceuticals, Inc.
$101
COMSORT, Inc
$100
UroGen Pharma, Inc.
$81
ConvaTec Inc.
$77
PROCEPT BioRobotics Corporation
$73
Cook Medical LLC
$72
Novartis Pharmaceuticals Corporation
$65
Rochester Medical Corporation
$61
UROGEN PHARMA, INC.
$61
AstraZeneca Pharmaceuticals LP
$60
Blue Earth Diagnostics Limited
$59
Telix Pharmaceuticals
$59
DENTSPLY IH AB
$55
Myovant Sciences Inc.
$53
Axonics Modulation Technologies, Inc.
$50
MEDIVATION FIELD SOLUTIONS LLC
$49
Sun Pharmaceutical Industries Inc.
$46
IMMUNITYBIO, INC.
$45
Mission Pharmacal Company
$42
CooperSurgical, Inc.
$41
Aytu BioScience, Inc
$40
Laborie Medical Technologies Corp.
$38
Zyla Life Sciences, Inc.
$34
Alnylam Pharmaceuticals Inc.
$34
Foundation Medicine, Inc.
$29
PROGENICS PHARMACEUTICALS, INC.
$26
Shire North American Group Inc
$24
Olympus America Inc.
$24
BOSTON SCIENTIFIC CORPORATION
$23
ACCORD HEALTHCARE, INC.
$23
Provepharm Inc.
$21
ROCHESTER MEDICAL CORPORATION
$18
Augmenix, Inc.
$16
Endo USA, Inc.
$15
COLOPLAST CORP
$12
Sagent Pharmaceuticals, Inc.
$12
Top 3 companies account for 43.6% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · ALTIS · ANKTIVA · AQUABEAM SYSTEM · Androgel · AquaBeam Robotic System · Axonics · Axonics r-SNM System · Axumin · BLUDIGO · BOTOX · BOTOX THERAPEUTIC · BRACANALYSIS CDX · Bulkamid · CAMCEVI · COOK · CURE CATHETER · ELIGARD · ERLEADA · EVENITY · Endosee · Erleada · FIRMAGON · FOUNDATIONONE · GEMTESA · GENERAL ONCOLOGY · GENERAL THERAPIES · GENERAL UTERINE TISSUE REMOVAL · GENERAL BPH · GENEXPERT · GENTLECATH · Glydo · ILLUCCIX · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · LOFRIC · LUPRON DEPOT · LYNPARZA · LithoVue · LoFric · Lupron · Lupron Depot · MAGIC3 · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · OXLUMO · PLUVICTO · PROLARIS · PROVENGE · PYLARIFY · Prolaris · SPEEDICATH · SPRIX · SUTENT · SpaceOAR · SpeediCath · Stendra · TOVIAZ · Trelstar · URIBEL · UROLIFT · Uribel · UroLift · UroLift System · Urocit-K · Urolift · Veozah · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (60%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for optician in PA.
Geographic Context
Opticians within 10 mi
725
Per 100K population
125.8
County median income
$88,576
Nearest hospital
BRYN MAWR HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bernstein is a clinical cardiology specialist, with above-average Medicare volume (top 3% in PA), with low-engagement industry engagement in the top 9% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bernstein experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Bernstein performed 1,850 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bernstein receive payments from pharmaceutical companies?
Yes. Dr. Bernstein received a total of $23,816 from 75 companies across 608 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bernstein's costs compare to other opticians in Bryn Mawr?
Dr. Bernstein's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bernstein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Bryn Mawr
Browse opticians in Bryn Mawr ranked by procedure volume and transparency data.
Highest volume
Top Opticians in PA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in PA
Which PA opticians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Lutonix, Inc. Payments to Doctors
See all physicians who received payments from Lutonix, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology